**Core Concept**
Lithium is a mood stabilizer used in the treatment of bipolar disorder, primarily due to its ability to modulate the activity of certain neurotransmitters and neuronal circuits in the brain. The introduction of lithium marked a significant shift in the management of bipolar disorder, offering a more targeted and effective treatment option.

**Why the Correct Answer is Right**
Lithium was first introduced by John Cade, an Australian psychiatrist, in 1949. Cade's pioneering work led to the discovery of lithium's therapeutic effects on bipolar disorder. Lithium works by inhibiting the reuptake of serotonin and norepinephrine, thereby increasing their concentrations in the synaptic cleft and modulating the activity of various neurotransmitter systems. This results in a stabilizing effect on mood.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect as lithium was not introduced by John F. Kennedy, who was an American politician and 35th President of the United States.
**Option B:** This option is incorrect as the introduction of lithium is attributed to John F. Cade, not Carl C. Pfeiffer, an American psychiatrist.
**Option C:** This option is incorrect as lithium was not introduced by Karl Manne Georg Siegel, a Swedish psychiatrist.
**Option D:** This option is incorrect as the introduction of lithium is attributed to John F. Cade, not Daniel X. Freedman, an American psychiatrist.

**Clinical Pearl / High-Yield Fact**
It's essential to remember that lithium has a narrow therapeutic index, meaning small changes in blood concentration can lead to toxicity. Regular monitoring of lithium levels is crucial to avoid adverse effects.

**Correct Answer: C. John Cade.**